Adam Crystal
President at Tango Therapeutics, Inc. (TNGX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $7.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 5SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 26,400116,343 held (−18%) | $24.45 | $646K | -2.6% |
| Oct 5SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 600115,743 held (−1%) | $25.32 | $15K | -6.0% |
| Sep 3SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 27,000115,743 held (−19%) | $22.37 | $604K | +6.4% |
| Aug 5SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 5,267137,476 held (−4%) | $26.79 | $141K | -11.1% |
| Aug 5SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 21,733115,743 held (−16%) | $27.35 | $594K | -12.9% |
| Jul 2SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 19,629123,114 held (−14%) | $29.34 | $576K | -18.8% |
| Jul 2SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 7,371115,743 held (−6%) | $30.25 | $223K | -21.3% |
| Jun 3SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 6,140136,603 held (−4%) | $22.25 | $137K | +7.0% |
| Jun 3SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 20,860115,743 held (−15%) | $23.06 | $481K | +3.3% |
| May 5SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 25,900116,843 held (−18%) | $21.19 | $549K | +12.4% |
| May 5SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 1,100115,743 held (−1%) | $22.00 | $24K | +8.2% |
| Apr 16SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 38,460112,622 held (−25%) | $25.00 | $962K | -4.8% |
| Apr 2SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 27,000112,622 held (−19%) | $21.20 | $572K | +12.3% |
| Mar 27SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 12,000112,622 held (−10%) | $20.11 | $241K | +18.4% |
| Mar 9SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 20,251112,622 held (−15%) | $15.00 | $304K | +58.7% |
| Feb 27SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 54,345132,873 held (−29%) | $12.77 | $694K | +86.5% |
| Feb 4SEC | TNGXTango Therapeutics, Inc. | Sell | 18,251187,419 held (−9%) | $12.26 | $224K | +94.2% |
| Feb 4SEC | TNGXTango Therapeutics, Inc. | Sell | 201187,218 held (−0%) | $12.90 | $3K | +84.6% |
- Sell
President Adam Crystal sold $646K of TNGX at $24.45 — pre-scheduled 10b5-1 plan sale.
- Sell
President Adam Crystal sold $15K of TNGX at $25.32 — pre-scheduled 10b5-1 plan sale.
- Sell
President Adam Crystal sold $604K of TNGX at $22.37 — pre-scheduled 10b5-1 plan sale.
- Sell
President Adam Crystal sold $141K of TNGX at $26.79 — pre-scheduled 10b5-1 plan sale.
- Sell
President Adam Crystal sold $594K of TNGX at $27.35 — pre-scheduled 10b5-1 plan sale.
- Sell
President Adam Crystal sold $576K of TNGX at $29.34 — pre-scheduled 10b5-1 plan sale.